Venous Thromboembolism Market Overview for 2026–2030 with Industry Insights
The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Does The Market Size Of The Venous Thromboembolism Market Compare Between 2026 And 2030?
The market for venous thromboembolism has shown steady expansion in recent years. It is anticipated to increase from $2.53 billion in 2025 to $2.63 billion in 2026, progressing at a compound annual growth rate (CAGR) of 3.9%. The historical growth of this market can be attributed to several factors, including an escalating incidence of venous thromboembolism, the rise of the aging population, a growing prevalence of sedentary lifestyles, enhanced clinical awareness concerning VTE risks, and the broadening of hospital-based thrombotic care provisions.
The venous thromboembolism market size is anticipated to demonstrate consistent expansion over the upcoming years. It is projected to reach $3.2 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. This projected growth during the forecast period is fueled by several factors, including the increasing integration of personalized anticoagulant therapies, a rising need for less invasive treatment approaches, the broadening of outpatient vte care structures, intensified investment in sophisticated diagnostic tools, and a heightened emphasis on managing thrombosis preventatively. Key developments expected in this period encompass the wider acceptance of novel oral anticoagulants, an escalating utilization of mechanical thrombectomy devices, a stronger emphasis on prompt diagnosis and risk assessment, the growth of home-based vte management initiatives, and enhanced oversight of anticoagulant therapy.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13001&type=smp
What Key Factors Are Shaping The Venous Thromboembolism Market Landscape?
The anticipated expansion of healthcare infrastructure is set to fuel the growth of the venous thromboembolism market in the coming period. The healthcare industry broadly refers to the combined and integrated sectors within the economic system that deliver products and services aimed at curing, preventing, rehabilitating, and offering palliative care to patients. This industry’s expansion is instrumental in developing the institutional infrastructure, policies, practices, and educational programs essential for supporting the execution of VTE prevention protocols. For example, in May 2023, the American Health Care Association, a US-based nonprofit organization, reported an increase in the number of hospitals in the US to 6,129, up from 6,093 in 2022. This demonstrates how the expanding healthcare industry is driving the growth of the venous thromboembolism market.
How Is Segmentation Applied In The Venous Thromboembolism Market Segment Analysis?
The venous thromboembolism market covered in this report is segmented –
1) By Type: Deep Vein Thrombosis, Pulmonary Embolism, Other Types
2) By Treatment: Anti-Clotting Medications, Mechanical Devices, Thrombolytic Therapy, Other Treatment
3) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users
Subsegments:
1) By Deep Vein Thrombosis (DVT): Proximal DVT, Distal DVT, Asymptomatic DVT
2) By Pulmonary Embolism (PE): Acute PE, Chronic PE, Submassive PE
3) By Other Types: Thrombophlebitis, Superficial Vein Thrombosis, Post-Thrombotic Syndrome
What Market Trends Are Affecting The Venous Thromboembolism Market?
Leading companies operating within the venous thromboembolism (VTE) market are concentrating on integrating advanced vascular-access sheath technology, such as laser-cut hypotube sheaths, to boost efficiency, safety, and procedural command. Laser-cut hypotube sheath technology employs a thin-walled metal tube that is precisely cut by laser, creating a sheath that is both adaptable and structurally reinforcing. This enables features like effortless navigation through blood vessels, reliable support during catheter insertion, and superior hemostasis management during interventions. For instance, in January 2025, Penumbra Inc., a US-based medical-device manufacturer, unveiled the Element Vascular Access System. This system is a laser-cut hypotube sheath specifically engineered for venous thromboembolism procedures, featuring the HemoLock dual-valve system for accurate hemostasis control and an atraumatic tip design alongside 17 F MaxID sizing for smooth delivery and compatibility with large-bore thrombectomy catheters. Element improves the efficiency of procedures, the trackability of devices, and physician control, potentially enhancing safety and treatment outcomes in VTE interventions.
Who Are The Companies Participating In The Venous Thromboembolism Market Environment?
Major companies operating in the venous thromboembolism market are Pfizer Inc., Johnson and Johnson Limited, Merck and Co Inc, AbbVie Inc, Bayer AG, Novartis AG, Sanofi-Aventis LLC, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Eli Lilly and Co Ltd, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd, Daiichi Sankyo Company Limited, Portola Pharmaceuticals Inc, Viatris Inc, AstraZeneca PLC, Medtronic plc, Boston Scientific Corporation, Stryker Corporation, Abbott Laboratories, AngioDynamics Inc, Terumo Corporation
Get The Full Venous Thromboembolism Market Report:
https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report
Which Region Has The Greatest Market Share In The Venous Thromboembolism Market?
North America was the largest region in the venous thromboembolism market in 2025. The regions covered in the venous thromboembolism market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Venous Thromboembolism Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/report/venous-thromboembolism-global-market-report
Browse Through More Reports Similar to the Global Venous Thromboembolism Market 2026, By The Business Research Company
Deep Vein Thrombosis Market Report 2026
https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report
Thrombophilia Market Report
https://www.thebusinessresearchcompany.com/report/thrombophilia-global-market-report
Vascular Embolization Market Report
https://www.thebusinessresearchcompany.com/report/vascular-embolization-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
